Advertisement
Screener

ProKidney Corp. (PROK) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum

1.7 / 5 stars · 8/23 Roast Me

ProKidney Corp. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum

ProKidney Corp. (PROK) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 3.60% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2026-03-18

  • ProKidney Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2025-03-31 was 4.10%, a 7.89% increase year-over-year.
  • ProKidney Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2024-03-31 was 3.80%, a 8.57% increase year-over-year.
  • ProKidney Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2023-03-31 was 3.50%.
  • ProKidney Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2025 was 3.60%, a 2.70% decline from fiscal 2024.
  • ProKidney Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2024 was 3.70%, a 5.71% increase from fiscal 2023.
  • ProKidney Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2023 was 3.50%, a 5.41% decline from fiscal 2022.
  • ProKidney Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2022 was 3.70%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month as first filed
2025-12-313.60%
10-K · filed 2026-03-18
2025-06-303.90%
10-Q · filed 2025-08-12
2025-03-314.10%
10-Q · filed 2025-05-12
2024-12-313.70%
10-K · filed 2026-03-18
3.60%
10-K · filed 2025-03-17
2024-09-303.70%
10-Q · filed 2024-11-12
2024-06-303.80%
10-Q · filed 2025-08-12
2024-03-313.80%
10-Q · filed 2025-05-12
2023-12-313.50%
10-K · filed 2025-03-17
2023-09-303.50%
10-Q · filed 2024-11-12
2023-06-303.50%
10-Q · filed 2024-08-09
2023-03-313.50%
10-Q · filed 2024-05-10
2022-12-313.70%
10-K · filed 2024-03-22